These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

61 related articles for article (PubMed ID: 1773910)

  • 1. Decreased creatinine clearance which may be observed during prostaglandin E1 therapy: is it reversible with discontinuation of therapy?
    Okada S; Miyai Y; Sato K; Higuchi T; Ichiki K; Tanokuchi S; Ishii K; Hamada H; Ota Z
    J Int Med Res; 1991; 19(6):493-6. PubMed ID: 1773910
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Influence of prostaglandin E1 on heavy proteinuria in slightly azotaemic diabetics.
    Okada S; Sato K; Higuchi T; Ichiki K; Tanokuchi S; Ishii K; Hamada H; Ota Z
    J Int Med Res; 1991; 19(2):171-3. PubMed ID: 1864454
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Influence of prostaglandin E1 on slight proteinuria in non-azotaemic diabetics.
    Okada S; Sato K; Higuchi T; Ichiki K; Tanokuchi S; Ishii K; Hamada H; Ota Z
    J Int Med Res; 1992 Feb; 20(1):94-7. PubMed ID: 1568524
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Does a dose of 40 micrograms/day prostaglandin E1 reduce creatinine clearance in a patient with diabetic nephropathy of the nephrotic type?
    Okada S; Hamada H; Ichiki K; Tanokuchi S; Ishii K; Ota Z; Hiraki Y
    J Int Med Res; 1992 Apr; 20(2):190-6. PubMed ID: 1521675
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of prostaglandin E1 on the renin-aldosterone system in patients with diabetic nephropathy.
    Okada S; Ichiki K; Tanokuchi S; Ishii K; Hamada H; Ota Z
    J Int Med Res; 1993; 21(3):126-32. PubMed ID: 8299855
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prostaglandin E1 for renal papillary necrosis in a patient with diabetes mellitus.
    Abe K; Ozono Y; Miyazaki M; Furusu A; Shioshita K; Sasaki O; Tsukasaki S; Harada T; Kohno S
    J Int Med Res; 1999; 27(2):90-5. PubMed ID: 10446696
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of prostaglandin E1 on renal haemodynamics in a patient with diabetic nephropathy.
    Okada S; Ogino Y; Ichiki K; Tanokuchi S; Ishii K; Hamada H; Ota Z; Hiraki Y
    J Int Med Res; 1991; 19(6):497-500. PubMed ID: 1773911
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of renal resistive index among patients with Type 2 diabetes with different levels of creatinine clearance and urinary albumin excretion.
    Afsar B; Elsurer R
    Diabet Med; 2012 Aug; 29(8):1043-6. PubMed ID: 22269249
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparative effect of lisinopril and lacidipine on urinary albumin excretion in patients with type 11 diabetic nephropathy.
    Salako BL; Finomo FO; Kadiri S; Arije A; Olatosin AO
    Afr J Med Med Sci; 2002 Mar; 31(1):53-7. PubMed ID: 12518931
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Improved kidney function with intravenous prostaglandin E1 in patients with terminal heart failure].
    Wutte M; Hülsmann M; Berger R; Rödler S; Frey B; Stanek B; Pacher R
    Wien Klin Wochenschr; 1998 Jul; 110(13-14):473-8. PubMed ID: 9746960
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immediate improvement of diabetic mononeuropathy after intravenous administration of prostaglandin E1.
    Shimizu H; Shimomura Y; Inukai T; Takahashi M; Uehara Y; Kobayashi I; Kobayashi S
    Jpn J Med; 1990; 29(2):222-5. PubMed ID: 2232371
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Postoperative intravenous infusion of alprostadil (PGE1) does not improve renal function in hepatic transplant recipients.
    Manasia AR; Leibowitz AB; Miller CM; Silverstein JH; Schwartz M; Delgiudice R; Vallabhajosula S; Oropello JM; Benjamin E
    J Am Coll Surg; 1996 Apr; 182(4):347-52. PubMed ID: 8605558
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Therapeutic effect of prostaglandin E1 on diabetic nephropathy: a one-year follow-up study].
    Li PF; Mu YR; Xin Y; Qu Y; Liao L
    Nan Fang Yi Ke Da Xue Xue Bao; 2010 Mar; 30(3):482-5. PubMed ID: 20335115
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of red wine on urinary protein, 8-hydroxydeoxyguanosine, and liver-type fatty acid-binding protein excretion in patients with diabetic nephropathy.
    Nakamura T; Fujiwara N; Sugaya T; Ueda Y; Koide H
    Metabolism; 2009 Aug; 58(8):1185-90. PubMed ID: 19481229
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation of prostaglandin E1 therapy for sudden deafness.
    Nakashima T; Kuno K; Yanagita N
    Laryngoscope; 1989 May; 99(5):542-6. PubMed ID: 2709943
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison between prostaglandin E1, and esmolol infusions in controlled hypotension during scoliosis correction surgery a clinical trial.
    Goma HM
    Middle East J Anaesthesiol; 2012 Feb; 21(4):599-604. PubMed ID: 23327033
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Value of the urinary albumin/creatinine ratio in the detection of microalbuminuria].
    Dézier JF; Le Reun M; Poirier JY
    Presse Med; 1988 May; 17(18):897-900. PubMed ID: 2968594
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Reproducibility of renal function measurements in adult men with diabetic nephropathy: research and clinical implications.
    Agarwal R
    Am J Nephrol; 2007; 27(1):92-100. PubMed ID: 17284896
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The telmisartan renoprotective study from incipient nephropathy to overt nephropathy--rationale, study design, treatment plan and baseline characteristics of the incipient to overt: angiotensin II receptor blocker, telmisartan, Investigation on Type 2 Diabetic Nephropathy (INNOVATION) Study.
    Makino H; Haneda M; Babazono T; Moriya T; Ito S; Iwamoto Y; Kawamori R; Takeuchi M; Katayama S
    J Int Med Res; 2005; 33(6):677-86. PubMed ID: 16372586
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identification of the stages of diabetic nephropathy at which angiotensin II receptor blockers most effectively suppress albuminuria.
    Ogawa S; Matsushima M; Mori T; Okamura M; Senda M; Sakamoto T; Nako K; Ito S
    Am J Hypertens; 2013 Sep; 26(9):1064-9. PubMed ID: 23775091
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.